CERTIFIED DIABETIC SERVICES INC 3
Accession 0001144204-11-011464
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 3:51 PM ET
Size
24.4 KB
Accession
0001144204-11-011464
Insider Transaction Report
- (indirect: By Vicis Capital Master Fund)
Series 6 Warrant to purchase Common Stock
Exercise: $0.15Exp: 2014-11-16→ Common Stock (5,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
BD-1 Warrant to purchase Common Stock
Exercise: $0.07Exp: 2010-09-17→ Common Stock (1,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
Placement Agent Series A Warrant to purchase Common Stock
Exercise: $0.10Exp: 2013-11-29→ Common Stock (58,400 underlying) - (indirect: By Vicis Capital Master Fund)
Series C Convertible Preferred Stock
Exercise: $0.05→ Common Stock (55,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series D Convertible Preferred Stock
Exercise: $0.07→ Common Stock (80,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 3 Warrant to purchase Common Stock
Exercise: $0.13Exp: 2011-02-05→ Common Stock (25,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 3 Warrant to purchase Common Stock
Exercise: $0.13Exp: 2011-06-26→ Common Stock (12,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 4 Warrant to purchase Common Stock
Exercise: $0.15Exp: 2013-06-26→ Common Stock (12,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
BD-2 Warrant to purchase Common Stock
Exercise: $0.07Exp: 2012-09-17→ Common Stock (1,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
BD Warrant to purchase Common Stock
Exercise: $0.05Exp: 2010-09-17→ Common Stock (3,300,000 underlying) - 3,571,900(indirect: By Vicis Capital Master Fund)
Common Stock
- (indirect: By Vicis Capital Master Fund)
Series E Convertible Preferred Stock
Exercise: $0.05→ Common Stock (11,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 1 Warrant to purchase Common Stock
Exercise: $0.07Exp: 2010-09-17→ Common Stock (25,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 2 Warrant to purchase Common Stock
Exercise: $0.07Exp: 2012-09-17→ Common Stock (25,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 4 Warrant to purchase Common Stock
Exercise: $0.15Exp: 2013-02-15→ Common Stock (25,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 5 Warrant to purchase Common Stock
Exercise: $0.10Exp: 2012-11-16→ Common Stock (5,500,000 underlying)
- (indirect: By Vicis Capital Master Fund)
Series 3 Warrant to purchase Common Stock
Exercise: $0.13Exp: 2011-06-26→ Common Stock (12,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 5 Warrant to purchase Common Stock
Exercise: $0.10Exp: 2012-11-16→ Common Stock (5,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
BD Warrant to purchase Common Stock
Exercise: $0.05Exp: 2010-09-17→ Common Stock (3,300,000 underlying) - (indirect: By Vicis Capital Master Fund)
BD-2 Warrant to purchase Common Stock
Exercise: $0.07Exp: 2012-09-17→ Common Stock (1,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series D Convertible Preferred Stock
Exercise: $0.07→ Common Stock (80,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series E Convertible Preferred Stock
Exercise: $0.05→ Common Stock (11,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 4 Warrant to purchase Common Stock
Exercise: $0.15Exp: 2013-02-15→ Common Stock (25,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 6 Warrant to purchase Common Stock
Exercise: $0.15Exp: 2014-11-16→ Common Stock (5,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
BD-1 Warrant to purchase Common Stock
Exercise: $0.07Exp: 2010-09-17→ Common Stock (1,500,000 underlying) - (indirect: By Vicis Capital Master Fund)
Placement Agent Series A Warrant to purchase Common Stock
Exercise: $0.10Exp: 2013-11-29→ Common Stock (58,400 underlying) - 3,571,900(indirect: By Vicis Capital Master Fund)
Common Stock
- (indirect: By Vicis Capital Master Fund)
Series C Convertible Preferred Stock
Exercise: $0.05→ Common Stock (55,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 1 Warrant to purchase Common Stock
Exercise: $0.07Exp: 2010-09-17→ Common Stock (25,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 2 Warrant to purchase Common Stock
Exercise: $0.07Exp: 2012-09-17→ Common Stock (25,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 3 Warrant to purchase Common Stock
Exercise: $0.13Exp: 2011-02-05→ Common Stock (25,000,000 underlying) - (indirect: By Vicis Capital Master Fund)
Series 4 Warrant to purchase Common Stock
Exercise: $0.15Exp: 2013-06-26→ Common Stock (12,500,000 underlying)
Footnotes (3)
- [F1]Represents the indirect holdings of Vicis Capital LLC. All of the foregoing represents securities held directly by Vicis Capital Master Fund. Vicis Capital LLC acts as investment advisor to Vicis Capital Master Fund and therefore has voting and dispositive power over all the foregoing shares. For the purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Vicis Capital LLC may be deemed to be the beneficial owner of, but hereby disclaims such beneficial ownership of, the foregoing shares.
- [F2]Immediately.
- [F3]None.
Documents
Issuer
CERTIFIED DIABETIC SERVICES INC
CIK 0001047153
Related Parties
1- filerCIK 0001047153
Filing Metadata
- Form type
- 3
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 3:51 PM ET
- Size
- 24.4 KB